In Sight : My Life in Science and Health Innovation.

Covering issues within the scientific community, In Sight is a deeply personal memoir of a woman's experience transitioning a major scientific treatment from grassroots development to commercial breakthrough.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Levy, Julia
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Toronto : University of Toronto Press, 2020.
Temas:
Levy, Julia G., > 1934-
Microbiologists > Canada > Biography.
College teachers > Canada > Biography.
Microbiology.
Chief executive officers > Canada > Biography.
Faculty
Microbiology
DISCOUNT-C.
IPO.
QLT.
STEM.
Visudyne.
biography.
biotechnology.
careers.
commercialisation of science.
macular degeneration.
memoir.
photodynamic.
therapy.
women in business.
women in science.
Microbiologie.
Chefs de direction > Canada > Biographies.
Microbiologistes > Canada > Biographies.
microbiology.
BIOGRAPHY & AUTOBIOGRAPHY > Personal Memoirs.
College teachers
Microbiologists
Canada
Personal Narrative
Autobiography
Biography
autobiographies (literary works)
Personal narratives
Autobiographies
Biographies
Personal narratives.
Autobiographies.
Biographies.
Récits personnels.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover
  • Title Page
  • Copyright
  • Dedication
  • Contents
  • Foreword
  • CHAPTER ONE: Waiting for the Other Shoe to Drop
  • CHAPTER TWO: Does Your Dog Always Sit in the Front Seat?
  • CHAPTER THREE: Where I Wanted to Be
  • CHAPTER FOUR: Life in Bed-Sits
  • CHAPTER FIVE: Woefully Outclassed
  • CHAPTER SIX: Whose Lab Do You Work in?
  • CHAPTER SEVEN: Earning My Stripes
  • CHAPTER EIGHT: Seeing the Light
  • CHAPTER NINE: Becoming Part of a Biotech Start-Up
  • CHAPTER TEN: Positioning QLT as a Photodynamic Therapy Company
  • CHAPTER ELEVEN: Colleagues at American Cyanamid Come to Our Rescue
  • CHAPTER TWELVE: The Nation's Blood Supply
  • CHAPTER THIRTEEN: PDT Is Different from Other Cancer Drugs
  • CHAPTER FOURTEEN: I Was Surprised and Not at All Pleased
  • CHAPTER FIFTEEN: Splitting Up
  • CHAPTER SIXTEEN: Failure Was Never an Option
  • CHAPTER SEVENTEEN: Nothing Can Prepare You for the Torture of ODAC
  • CHAPTER EIGHTEEN: Taking Big Steps in Our AMD Clinical Trials
  • CHAPTER NINETEEN: An Open and Respectful Relationship
  • CHAPTER TWENTY: Our Work on Age-Related Macular Degeneration Is Her Legacy
  • CHAPTER TWENTY-ONE: We at QLT Were on Pins and Needles
  • CHAPTER TWENTY-TWO: People Couldn't Stop Smiling
  • CHAPTER TWENTY-THREE: More Than a One-Trick Pony
  • CHAPTER TWENTY-FOUR: Launching the Product and Hoping for No Unpleasant Surprises
  • CHAPTER TWENTY-FIVE: Growing the Company
  • CHAPTER TWENTY-SIX: Time to Reflect
  • CHAPTER TWENTY-SEVEN: An Enormous Rush of Relief
  • CHAPTER TWENTY-EIGHT: A Biotech Company with a Lot of Money Is in Danger
  • CHAPTER TWENTY-NINE: I Thought These Problems Would Be Transient
  • CHAPTER THIRTY: Ongoing Headaches
  • CHAPTER THIRTY-ONE: He Felt Thoroughly Betrayed
  • CHAPTER THIRTY-TWO: Problems with Activist Shareholders
  • CHAPTER THIRTY-THREE: New Opportunity
  • Acknowledgments
  • About the Author
  • Index

Ejemplares similares